Adverse events in radiation oncology: A case series from wake up safe, the pediatric anesthesia quality improvement initiative by Christensen, Robert E. et al.
R E S E A R CH R E PO R T
Adverse events in radiation oncology: A case series from
wake up safe, the pediatric anesthesia quality improvement
initiative
Robert E. Christensen1 | Rebecca C. Nause‐Osthoff1 | Jeffrey C. Waldman2 |
Daniel E. Spratt3 | Jason W. D. Hearn3
1Department of Anesthesiology, University
of Michigan, Ann Arbor, Michigan
2US Anesthesia Partners Colorado,
Greenwood Village, Colorado
3Radiation Oncology, University of
Michigan, Ann Arbor, Michigan
Correspondence
Robert E. Christensen, Department of
Anesthesiology, CS Mott Children's Hospital,
Ann Arbor, MI.
Email: robertec@med.umich.edu
Section Editor: Joseph Cravero
Abstract
Background: Radiation therapy in pediatric patients often requires anesthesia and
poses environmental challenges. Monitoring must be done remotely to limit radia-
tion exposure to the provider. Airway access can be limited by masks or frames.
Care is often delivered in relatively inaccessible locations in the hospital. While indi-
vidual institutions have reported their outcomes, this case series aims to review a
multicenter registry of significant adverse events and make recommendations for
improved care.
Methods: Wake Up Safe: The Pediatric Quality Improvement Initiative maintains a
multisite, voluntary registry of pediatric perianesthetic significant adverse events.
This was queried for reports from radiation oncology from January 1, 2010 to May
10, 2018. The database contained 3,379 significant adverse events from approxi-
mately 3.3 million anesthetics. All 33 institutions submitted data on a standardized
form to a central data repository (Axio Research, Seattle Washington). Prior to each
significant adverse events case submission, three anesthesiologists who were not
involved in the event analyzed the event using a standardized root cause analysis
method to identify the causal or contributing factor(s).
Results: Six significant adverse events were identified. In three, incorrect program-
ming of a propofol infusion resulted in overdose. In case one, the 3‐year‐old
female became hypotensive, requiring vasopressors and volume resuscitation. In
the second, the 2‐year‐old female experienced airway obstruction and apnea
requiring chin lift. In case three, the child suffered no consequences despite a
noted overdose of propofol infusion. In case four, a 2‐year‐old female with recent
respiratory infection suffered laryngospasm during an unmonitored transport to
the recovery area. She developed profound oxygen desaturation with bradycardia
treated with succinylcholine and chest compressions. In case five, a 6‐year‐old for-
mer premature child suffered laryngospasm at the conclusion of mask creation
under general anesthesia with a laryngeal mask airway. The radiation mask delayed
recognition of copious secretions. Finally, in case six, a 6‐year‐old undergoing
stereotactic radiosurgery in a head halo suffered bronchospasm and unintended
extubation during therapy which required multiple attempts at reintubation by
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multiple providers ultimately requiring cancellation of the treatment and transport
to the intensive care unit.
Conclusion: There were few radiation oncology significant adverse events, but anal-
ysis has led to the identification of several specific opportunities for improvement in
pediatric anesthesia for radiation oncology.
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airway obstruction, anesthesia, child, medication errors, quality improvement, radiation
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1 | INTRODUCTION
Radiation therapy in pediatric patients may require anesthesia, which
can provide unique challenges to the pediatric anesthesia provider.
Care is often provided in isolated locations in the hospital, limiting
availability of additional staff and resources. Furthermore, the recog-
nition and treatment of a patient's clinical status may be delayed
due to remote monitoring and safety barriers to prevent radiation
exposure to care team members.
Anesthetic practice has evolved for radiation oncology cases
from ketamine‐based sedation1 or inhalation techniques2 to propo-
fol‐based sedation.3 Individual case reports4 and institutions1–3,5–,13
have reported their outcomes, including rates of respiratory and
other complications, to be similar to outcomes for other sedation
cases performed out of an operating room.14 No multi‐institutional
safety studies were found in our literature search.
In this case series, we reviewed all significant adverse events
(SAE) reported to the Wake Up Safe database and found six cases
occurring in radiation oncology. Wake Up Safe: The Pediatric Anes-
thesia Quality Improvement Initiative is a multisite voluntary registry
of pediatric perianesthetic SAE. In 2006, the Quality and Safety
Committee of the Society for Pediatric Anesthesia initiated a quality
improvement project for the specialty of pediatric anesthesiology
that ultimately resulted in the development of Wake Up Safe, a
patient safety organization that maintains a national registry of de‐
identified serious adverse events.15,16 The ultimate goal of Wake Up
Safe is to implement changes in processes of care that improve the
quality and safety of anesthetic care provided to pediatric patients
nationwide. Reporting of this case series is aimed to describe SAE
that occurred during pediatric anesthetics provided in the unusual
environment of radiation oncology and provide recommendations for
improved care.
2 | MATERIALS AND METHODS
Member institutions of Wake Up Safe submit quarterly data regard-
ing the types and numbers of anesthetics performed, including ASA
physical status, surgical billing codes, age, and gender for all cases at
their institution. They also submit more detailed, though de‐identi-
fied, case information pertaining to specific SAE as defined by Wake
Up Safe guidelines.17 Appendix S1 lists the specific questions for
each type of event and possible responses. The original anesthetic
records are not submitted. In designing the forms, Wake Up Safe
sought to balance data capture with data entry burden for practicing
anesthesiologists.
Prior to each case submission, three anesthesiologists from the
reporting institution who were not involved in the event analyze the
event using a standardized root cause analysis method to identify
the causal or contributing factor(s).18 Representatives from each
member institution received education on root cause analysis
methodology prior to participation in an effort to standardize case
evaluation across sites.
For the purpose of this case series, the database was queried for
all events reported between January 1, 2010 and May 10, 2018 to
identify all SAE that occurred in children (≤18 years of age) in the
radiation oncology setting or during transport to the post anesthesia
care unit (PACU) from radiation oncology. All reported data were
extracted, including: demographics, comorbid conditions, reported
contributors to the significant adverse events (primary and
What is already known
 Radiation therapy in pediatric patients often requires
anesthesia and, while generally safe, poses environmental
challenges. Monitoring must be done remotely to limit
radiation exposure to providers, patients are immobilized
in masks or frames, and care is often delivered in distant
locations.
What this article adds
 Based on the adverse events described, measures that
may systematically reduce risks include: (1) double check
of infusion pumps and use of cameras to visualize infu-
sions; (2) continuous monitoring, including during trans-
port; (3) consideration of alternatives to succinylcholine
when feasible; and (4) particular vigilance to maintain air-
way patency when radiation masks or frames are used.
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secondary), management details, and outcomes, including survival
and extent of harm. Narrative data were edited for typographical
errors, brevity, and clarity.
While quarterly data regarding the number and types of anes-
thetics performed at each institution are reported, the use of a gen-
eric “anesthesia for other radiologic procedures” billing code for
services provided in radiation oncology made it impossible to consis-
tently separate these anesthetics. We have reported the numbers of
anesthetics that had a clearly identifiable radiation oncology billing
code, but expect this to be a significant underestimate.
3 | RESULTS
The Wake Up Safe database contained 3379 adverse events from
3.35 million anesthetics at 33 institutions as of May 10, 2018. The
data query yielded six SAE on six different patients, described in
Table 1. A total of 48, 578 cases included a radiation oncology bill-
ing code for an incidence of approximately 1/8000. This may be an
overestimate as generic billing codes such as “Anesthesia for other
radiologic procedure” were present in place of radiation oncology
codes for some of the reported SAE. For each of the SAE, while
there are many details available (see Appendix S1), the standardized
forms does not capture all the granular details present in an anes-
thetic record. We do not have access to the vital signs, specific tim-
ing of interventions, etc.
Consistent with the outpatient nature of most radiation therapy,
all events occurred on weekdays during normal hours. There were
no handovers associated with these events. Harm in all cases was
limited to no harm or additional treatment, with no reported perma-
nent consequences. All cases reported anesthesia as the primary
cause of the event.
In the first case, unrecognized incorrect programming by a trai-
nee of a propofol infusion resulted in overdose. This was recognized
when the infusion pump alarmed audibly that the syringe was almost
empty. The 3‐year‐old female became hypotensive, requiring ephe-
drine and fluid bolus.
In the second case, the propofol infusion was entered by a trai-
nee in milligrams per kilogram per minute instead of micrograms per
kilogram per minute, resulting in overdose. This error was recognized
when the 2‐year‐old patient became apneic. The airway obstruction
responded to chin lift and nasal cannula oxygen while a fluid bolus
was also administered.
In the third case, an anesthesiologist providing care directly pro-
grammed the infusion pump for micrograms per kilogram per hour
instead of the intended micrograms per kilogram per minute. This
was not recognized until the case was complete, but did not result
in any harm to the patient.
In case four, a 2‐year‐old female with recent respiratory infection
suffered laryngospasm during an unmonitored transport. This was
recognized when the patient appeared “dusky.” Succinylcholine and
positive pressure ventilation were administered during transport, but
this progressed to profound desaturation. Upon application of moni-
tors in the postanesthesia care unit, she was bradycardic.
Approximately 30 seconds of chest compressions were performed.
She was intubated and rapidly recovered. She was extubated in the
recovery area and admitted to intensive care for observation. While
in the ICU, she had mild stridor treated with dexamethasone.
In case five, a 6‐year‐old former premature child suffered laryn-
gospasm at the conclusion of computed tomography simulation in
radiation oncology under general anesthesia with a laryngeal mask
airway. When the radiation mask was removed at the end of the
procedure, copious secretions were seen and thought to have trig-
gered his airway reflexes. The laryngeal mask airway was removed,
succinylcholine was given, the patient was intubated and transported
to intensive care.
In case six, a 6‐year‐old undergoing stereotactic radiosurgery in
radiation oncology in a head halo suffered bronchospasm and unin-
tended extubation during therapy. Initially, wheezing was heard and
the tape securing the endotracheal tube was noted to be peeling.
The “usual device” for securing the endotracheal tube was missing
that day. Multiple direct laryngoscopies by the nurse anesthetist and
anesthesiologist appeared to show the endotracheal tube in position,
but the halo frame was impeding visualization. This proceeded to
loss of endtidal carbon dioxide and bradycardic cardiac arrest. Epi-
nephrine was administered both intravenously and via endotracheal
tube. Repeat direct laryngoscopy by another anesthesiologist with
the frame removed showed that the tube was in the esophagus. The
patient was reintubated and rapidly recovered. The case was can-
celled, and the patient transported to intensive care, waking there
without apparent deficits.
4 | DISCUSSION
There were few radiation oncology SAE in the Wake Up Safe data-
base, but these allowed recognition of possible preventive measures.
While the nature of these events (three respiratory SAE and three
medication errors) are consistent with the overall WUS data,19 the
unique environment associated with administering pediatric anes-
thetics for radiation oncology contributed to all events in this series.
In the first three cases, remote monitoring of the patient and
equipment via camera with poor lighting may have impaired prompt
recognition of drug administration errors. In case four, the prolonged
transport from the treatment room to recovery area of an unmoni-
tored patient affected prompt detection and treatment of laryn-
gospasm. Though hypoxemia is the most likely cause of bradycardia
in this patient, it is possible the patient developed hyperkalemia from
administration of succinylcholine. Radiation therapy as a risk factor
for hyperkalemic response to succinylcholine has been previously
described in a human case report20 and animal data,21 but no elec-
trolyte or electrocardiographic information were reported to confirm
this. In the fifth case, the process of making a facial mask to prevent
head movement during treatment made airway management more
challenging. In similar manner, the halo used for stereotactic radio-
surgery impaired airway management in the last case.
This case series highlights potential safety concerns for providing
anesthesia services in radiation oncology. To prevent the medication
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errors, previously published recommendations regarding medication
infusions,19 such as two provider checks, intelligent pumps, and bar
coding should be implemented. Particular to the radiation oncology
environment, remote monitoring cameras should also adequately
visualize the infusion pumps. Continuous monitoring of oxygenation
and/or ventilation throughout anesthetic care including during trans-
port with portable monitors, as well as the availability of a nearby
recovery area may mitigate the risk of transporting an anesthetized
patient. Finally, airway patency and access may be impeded in the
presence of radiation halos and masks. Consideration should be
given to having additional help and airway equipment such as
fiberoptic or video laryngoscopes available. Removal of the halo or
mask should also be implemented early as this will require some time
to accomplish.
The voluntary, multicenter nature of the database used in this
study posed the potential for selection and reporting biases. In par-
ticular, the literature reported a significant incidence (>3%) of line
sepsis,10 but none were reported here. The data reported were lim-
ited such that important information such as laboratory results, tim-
ing of vasoactives, nadir oxygen saturation, etc were unobtainable.
Erroneous data entry is also a concern. The use of a generic billing
code may have resulted in undercounting of the number of anes-
thetics in radiation oncology. This likely resulted in an overestimate
of the incidence of SAE and precluded a comprehensive analysis of
factors systematically associated with significant adverse events. Fur-
thermore, despite centralized training, specific guidelines, and defini-
tions, root cause analyses methodology may have differed between
institutions. These data must therefore be interpreted with caution.
In conclusion, there were few radiation oncology SAE identified
in the Wake Up Safe database, but these exposed opportunities for
quality improvement particular to this environment. In particular,
routine use of remote camera monitoring of infusion pumps during
therapy would detect problems. Monitoring during transport to
recovery and avoidance of succinylcholine should also be considered.
Lastly, airway patency and access may be impaired by radiation
masks and halos, so early removal of these devices in the event of
airway compromise should be planned.
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